BioTechGrid

Microprotein Atlas Links Brain Immune Cell Dysfunction to Alzheimer’s

September 16, 2026

Credit: nopparit / iStock / Getty Images Plus Scientists studying Alzheimer’s disease have long focused on genes, proteins, and cells,…

Genetics

Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles

September 15, 2026

Neurons [Evgenii Kovalev / E+/ Getty Images] The results of a study by researchers at the University of Colorado Anschutz…

Genetics

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

September 15, 2026

Emily Gaither Engineer III, Downstream PurificationThermo Fisher Scientific Panelist Emily Gaither Emily Gaither is a bioprocessing engineer specializing in downstream…

Genetics

Consolidating Antibody Discovery Data with an AI Platform

September 15, 2026

Credit: Metamorworks/Getty Images FairJourney Bio (FJBio) selected the Sapio Scientific AI platform, including Sapio’s LIMS, ELN, and AI co-scientist solutions…

Biotechnology

FDA launches pilot program to speed up sluggish phase 1 trials

September 15, 2026

After teasing a new initiative to speed up early-stage clinical trials over the summer, the FDA today opened a pilot…

Biotechnology

Connect’s Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope

September 15, 2026

Connect Biopharma’s hopes of dethroning Dupixent took a knock as its IL-4/IL-13 blocker missed the primary endpoint of a phase…

Medical Technology

Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure

September 15, 2026

The Mayo Clinic has partnered with Thermo Fisher Scientific to launch a new group focused on reaping large-scale data that…

Biotechnology

Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech

September 15, 2026

Eli Lilly’s ongoing attempt to strengthen its genetic medicine offering has seen the company pledge up to $237 million in…

Medical Technology

Newly formed Jaguar acquires Afib device assets from J&J

September 15, 2026

Jaguar LAA, a newly formed medtech, has acquired assets that are part of Johnson & Johnson’s AFib device Laminar program…

Biotechnology

Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial fail

September 15, 2026

Sionna Therapeutics is laying off almost half its workforce as the company recovers from the failure of its closely watched…

Microprotein Atlas Links Brain Immune Cell Dysfunction to Alzheimer’s

Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Consolidating Antibody Discovery Data with an AI Platform

FDA launches pilot program to speed up sluggish phase 1 trials

Connect’s Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Microprotein Atlas Links Brain Immune Cell Dysfunction to Alzheimer’s

Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Consolidating Antibody Discovery Data with an AI Platform

FDA launches pilot program to speed up sluggish phase 1 trials

Connect’s Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope

Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure

Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech

Newly formed Jaguar acquires Afib device assets from J&J

Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial fail

Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure

Newly formed Jaguar acquires Afib device assets from J&J

After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer

J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg